Literature DB >> 3708621

Phase II trial of esorubicin in advanced pancreatic adenocarcinoma.

D W Blayney, D A Goldberg, L A Leong, B I Carr, J H Doroshow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708621

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  1 in total

1.  Phase II evaluation of esorubicin (4'deoxydoxorubicin) in pancreatic adenocarcinoma: a Southwest Oncology Group study.

Authors:  C B Vaughn; S E Salmon; T R Fleming
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.